minoxidil has been researched along with Headache in 5 studies
Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.
Headache: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Topically administered minoxidil is of equal efficacy as diltiazem in the treatment of chronic anal fissure with low frequency of adverse effects." | 9.27 | Topical Minoxidil Versus Topical Diltiazem for Chemical Sphincterotomy of Chronic Anal Fissure: A Prospective, Randomized, Double-Blind, Clinical Trial. ( Ala, S; Alvandipour, M; Khalvati, M; Koulaeinejad, N; Yazdanicharati, J, 2018) |
| "Thirteen patients whose hypertension had been resistant to conventional drug therapy, had minoxidil added to their regimen in doses from 5 to 60 mg/day." | 9.04 | Clinical and haemodynamic effects of minoxidil in refractory hypertension. ( Clarkson, AR; Frewin, DB; Jackson, B; Lawrence, JR; Robinson, MA; Wilson, LL; Zacest, R, 1976) |
| "Topically administered minoxidil is of equal efficacy as diltiazem in the treatment of chronic anal fissure with low frequency of adverse effects." | 5.27 | Topical Minoxidil Versus Topical Diltiazem for Chemical Sphincterotomy of Chronic Anal Fissure: A Prospective, Randomized, Double-Blind, Clinical Trial. ( Ala, S; Alvandipour, M; Khalvati, M; Koulaeinejad, N; Yazdanicharati, J, 2018) |
| "Thirteen patients whose hypertension had been resistant to conventional drug therapy, had minoxidil added to their regimen in doses from 5 to 60 mg/day." | 5.04 | Clinical and haemodynamic effects of minoxidil in refractory hypertension. ( Clarkson, AR; Frewin, DB; Jackson, B; Lawrence, JR; Robinson, MA; Wilson, LL; Zacest, R, 1976) |
| "The major concern regarding the use of low-dose oral minoxidil (LDOM) for the treatment of hair loss is the potential risk of systemic adverse effects." | 1.62 | Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. ( Bhoyrul, B; Hermosa-Gelbard, A; Jaén-Olasolo, P; Jerjen, R; Jimenez-Cauhe, J; John, JM; Koh, WL; Lo-Sicco, K; Moreno-Arrones, ÓM; Piraccini, BM; Pirmez, R; Poa, JE; Rodrigues-Barata, R; Rudnicka, L; Saceda-Corralo, D; Salas-Callo, CI; Shapiro, J; Sinclair, R; Starace, M; Tosti, A; Trindade de Carvalho, L; Vañó-Galván, S; Vincenzi, C; Waskiel-Burnat, A; Yin, L; Zamorano, JL, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sanabria, B | 1 |
| Vanzela, TN | 1 |
| Miot, HA | 1 |
| Müller Ramos, P | 1 |
| Vañó-Galván, S | 1 |
| Pirmez, R | 1 |
| Hermosa-Gelbard, A | 1 |
| Moreno-Arrones, ÓM | 1 |
| Saceda-Corralo, D | 1 |
| Rodrigues-Barata, R | 1 |
| Jimenez-Cauhe, J | 1 |
| Koh, WL | 1 |
| Poa, JE | 1 |
| Jerjen, R | 1 |
| Trindade de Carvalho, L | 1 |
| John, JM | 1 |
| Salas-Callo, CI | 1 |
| Vincenzi, C | 1 |
| Yin, L | 1 |
| Lo-Sicco, K | 1 |
| Waskiel-Burnat, A | 1 |
| Starace, M | 1 |
| Zamorano, JL | 1 |
| Jaén-Olasolo, P | 1 |
| Piraccini, BM | 1 |
| Rudnicka, L | 1 |
| Shapiro, J | 1 |
| Tosti, A | 1 |
| Sinclair, R | 1 |
| Bhoyrul, B | 1 |
| Alvandipour, M | 1 |
| Ala, S | 1 |
| Khalvati, M | 1 |
| Yazdanicharati, J | 1 |
| Koulaeinejad, N | 1 |
| Andersson, O | 1 |
| Sivertsson, R | 1 |
| Zacest, R | 1 |
| Frewin, DB | 1 |
| Robinson, MA | 1 |
| Wilson, LL | 1 |
| Lawrence, JR | 1 |
| Clarkson, AR | 1 |
| Jackson, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomised, Crossover Bioavailability Clinical Trial of Oral Minoxidil 1 MG, After Single and Multiple Dose Administration to Healthy Volunteers Under Fasting Conditions.[NCT06015516] | Phase 1 | 14 participants (Anticipated) | Interventional | 2024-02-29 | Not yet recruiting | ||
| International Phase III, Multi Center, Randomized, Double Blind, Placebo and Active Controlled and Parallel Group Clinical Trial to Evaluate the Efficacy and Safety of Oral Minoxidil 1 mg in Female Patients With Androgenetic Alopecia[NCT05888922] | Phase 3 | 520 participants (Anticipated) | Interventional | 2024-03-31 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for minoxidil and Headache
| Article | Year |
|---|---|
Topical Minoxidil Versus Topical Diltiazem for Chemical Sphincterotomy of Chronic Anal Fissure: A Prospective, Randomized, Double-Blind, Clinical Trial.
Topics: Administration, Topical; Adolescent; Adult; Blood Pressure; Chronic Disease; Diltiazem; Double-Blind | 2018 |
Clinical and haemodynamic effects of minoxidil in refractory hypertension.
Topics: Adult; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Drug Resistance; Female; Headache; | 1976 |
3 other studies available for minoxidil and Headache
| Article | Year |
|---|---|
Adverse effects of low-dose oral minoxidil for androgenetic alopecia in 435 patients.
Topics: Adult; Alopecia; Body Weight; Dermatologic Agents; Headache; Humans; Hypertrichosis; Male; Minoxidil | 2021 |
Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Child; Dizziness; Edema; | 2021 |
Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Child; Dizziness; Edema; | 2021 |
Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Child; Dizziness; Edema; | 2021 |
Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Child; Dizziness; Edema; | 2021 |
Renal function and vascular resistance during long-term minoxidil treatment of severe hypertension.
Topics: Blood Pressure; Creatinine; Edema; Glomerular Filtration Rate; Headache; Humans; Hypertension; Hyper | 1980 |